Accéder au contenu
Merck

Generating human artery and vein cells from pluripotent stem cells highlights the arterial tropism of Nipah and Hendra viruses.

Cell (2022-06-24)
Lay Teng Ang, Alana T Nguyen, Kevin J Liu, Angela Chen, Xiaochen Xiong, Matthew Curtis, Renata M Martin, Brian C Raftry, Chun Yi Ng, Uwe Vogel, Angelika Lander, Benjamin J Lesch, Jonas L Fowler, Alyssa R Holman, Timothy Chai, Siva Vijayakumar, Fabian P Suchy, Toshinobu Nishimura, Joydeep Bhadury, Matthew H Porteus, Hiromitsu Nakauchi, Christine Cheung, Steven C George, Kristy Red-Horse, Joseph B Prescott, Kyle M Loh
RÉSUMÉ

Stem cell research endeavors to generate specific subtypes of classically defined "cell types." Here, we generate >90% pure human artery or vein endothelial cells from pluripotent stem cells within 3-4 days. We specified artery cells by inhibiting vein-specifying signals and vice versa. These cells modeled viral infection of human vasculature by Nipah and Hendra viruses, which are extraordinarily deadly (∼57%-59% fatality rate) and require biosafety-level-4 containment. Generating pure populations of artery and vein cells highlighted that Nipah and Hendra viruses preferentially infected arteries; arteries expressed higher levels of their viral-entry receptor. Virally infected artery cells fused into syncytia containing up to 23 nuclei, which rapidly died. Despite infecting arteries and occupying ∼6%-17% of their transcriptome, Nipah and Hendra largely eluded innate immune detection, minimally eliciting interferon signaling. We thus efficiently generate artery and vein cells, introduce stem-cell-based toolkits for biosafety-level-4 virology, and explore the arterial tropism and cellular effects of Nipah and Hendra viruses.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
KT5720, A potent, specific, cell-permeable, reversible and ATP-competitive inhibitor of protein kinase A (Ki = 56 nM) that is prepared by a chemical modification of K-252a.
Sigma-Aldrich
PI 3-K inhibitor IX, PIK-90, The PI 3-K inhibitor IX, PIK-90, also referenced under CAS 677338-12-4, controls the biological activity of PI 3-K. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.